<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Palatino;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:917787010;
mso-list-template-ids:996853634;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><b><span style="font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.dresnerfoundation.org_mdsrf-2Ddescription_&d=DwMFAg&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=P1IDwTp7bh2kFrra4asUvI0SgxBtA_0Kp5mBH7U-5Mw&s=j_PW7ZXar2OQp3KC1IZJ8I73gVBBaK9AGZ9cA2hjZV0&e=" target="_blank">Vera and Joseph Dresner Foundation: Myelodysplastic Syndromes Research Fund</a><o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-family:Palatino">The Vera and Joseph Dresner Foundation’s MDS Research Fund (MDSRF) seeks to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders and expands the foundation’s
investments in support of cutting-edge basic, translational, and clinical MDS research with the potential to establish future standards of care and, ultimately, a cure. The foundation will consider proposals in two categories from individuals at university,
college, hospital, or laboratory institutions for support of research in MDS or related disorders:
<b>Early Career Awards of up to $125,000 per year over two years</b> will be awarded to eligible investigators who are less than five years from completion of their fellowship training or postdoctoral program and/or have not previously been awarded an RO1 grant
or its equivalent. <b>Established Investigator Awards of up to $250,000 per year over two years</b> will be awarded to eligible investigators who are five or more years from completion of their fellowship training or postdoctoral program, or to applicants
who have previously received an Early Career Award from the foundation or an RO1 grant or its equivalent.
<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">Letter of intent due March 22, 2019.
<span style="color:red">Med-RA deadline to receive draft documents: March 8.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__grants.nih.gov_grants_guide_pa-2Dfiles_PAR-2D19-2D185.html&d=DwMFAg&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=P1IDwTp7bh2kFrra4asUvI0SgxBtA_0Kp5mBH7U-5Mw&s=cA2f4hDO33M5oQ7SJantuMJdsqyq-OKT4k2yprPMzkY&e=" target="_blank">Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed)</a><o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-family:Palatino">The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHGRI R25 program is to support educational activities that
complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino">To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on <b>Courses for Skills Development</b>:<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">(1) Short-term, advanced courses</span></b><span style="font-family:Palatino"> that are intended to disseminate, to a larger scientific audience, new techniques, methods, or analyses related to the
mission of the NHGRI. Short-term courses are two weeks or less in duration.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">(2) Long-term, skills development courses</span></b><span style="font-family:Palatino"> should provide innovative, state-of-the-art, evidence-based education related to the mission of the NHGRI. Long-term
courses are more than two weeks, but less than one year.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino">Course offerings should be targeted to individuals in careers at the doctoral level and beyond; are expected to be hosted by academic or research institutions where the staff and faculty have research
experience in the proposed area of the course and have experience in training; should include as faculty established investigators or scholars actively working in the area of instruction; and should be offered annually. Short-and long-term courses should be
offered in areas related to genome sciences, genomic medicine or ELSI.<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="mso-list:l0 level1 lfo1"><span style="font-family:Palatino">Genome Sciences: NHGRI has been at the forefront of genomics research. Courses that expose participants to basic genomic science concepts are acceptable; however, expanding
the knowledge and skill set in the quantitative and informational sciences is critically necessary for developing future leaders in genomics. Thus, the courses should emphasize cross-training in bioinformatics, biostatistics, and quantitative sciences.<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l0 level1 lfo1"><span style="font-family:Palatino">Genomic Medicine: The implementation of genomics into medicine requires that clinicians be provided with the knowledge and skills to effectively apply genomics in their
practices. With advances in genomic technology, this course seeks to provide an opportunity for clinicians to become genomics-literate to improve the delivery of healthcare in the era of genomic medicine. Courses should provide training in fundamental principles
of genetics in addition to tailored settings in which genomics-based care will be delivered, such as through routine primary care, specialized genetic clinics, or pharmacists or other allied health personnel.<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l0 level1 lfo1"><span style="font-family:Palatino">Ethical, Legal, and Social Implications (ELSI): NHGRI has also addressed the many ethical, legal and social implications (ELSI) that have been raised by genomics research.
Discussion and dissemination of new and emerging ELSI issues would keep the community updated and alerted to issues that should be anticipated in genomics research involving human participants. Courses designed to cross-train genomic researchers and ELSI scholars
are particularly encouraged.<o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-family:Palatino">Syllabi, handouts, and videos must be made available and easily assessible to the public electronically. Proposed courses may use a traditional in-person approach, online approach or a combination of both.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">Standard dates apply. Due May 28, 2019.
<span style="color:red">Med-RA deadline to receive draft documents for May submission: May 13.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><b><span style="font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.nsf.gov_pubs_2019_nsf19547_nsf19547.htm-3FWT.mc-5Fid-3DUSNSF-5F25-26WT.mc-5Fev-3Dclick&d=DwMFAg&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=P1IDwTp7bh2kFrra4asUvI0SgxBtA_0Kp5mBH7U-5Mw&s=8zSuzsy8N7KeD6-lwHtvts3Uso-H-L-Dxfl9_eobgtI&e=" target="_blank">NSF / NIH: Approach to Analyzing and Innovating the Biomedical Research Enterprise (SCISIPBIO)</a><o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-family:Palatino">SCISIPBIO supports research that advances the scientific basis of science and innovation policy, with a focus on the biomedical sciences. Consistent with the SciSIP program, SCISIPBIO will fund the development
of models, analytical tools, data and metrics that can inform science policy and the development of the scientific enterprise. SCISIPBIO welcomes individual and collaborative research projects and places a high priority on interdisciplinary research and on
broadening participation.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">Due May 9, 2019 and September 9, 2019.
<span style="color:red">Med-RA deadline to receive draft documents for May submission: April 25.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><b><span style="font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">Adolescent Brain Cognitive Development (ABCD) Study (R21 / R01 - Clinical Trial Not Allowed)<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__grants.nih.gov_grants_guide_pa-2Dfiles_PAR-2D19-2D163.html&d=DwMFAg&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=P1IDwTp7bh2kFrra4asUvI0SgxBtA_0Kp5mBH7U-5Mw&s=th7qSR_brR-GoZgaZikk13kOD5VC5BQav41e6K8af-k&e=" target="_blank">R21</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__grants.nih.gov_grants_guide_pa-2Dfiles_par-2D19-2D162.html&d=DwMFAg&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=P1IDwTp7bh2kFrra4asUvI0SgxBtA_0Kp5mBH7U-5Mw&s=buah9qCJj1FJ4dRSRsfA7VJ_P780FQXdrmRlJ_wtyZI&e=" target="_blank">R01</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino">The Adolescent Brain Cognitive Development (ABCD) Study is collecting data on health and mental health, cognitive function, substance use, cultural and environmental factors, and brain structure and function
from youth starting when they are 9-10 years-old and following them longitudinally to early adulthood. These data will be made available to the scientific community through the NIMH Data Archive. The purpose of these Funding Opportunity Announcements is to
encourage applications proposing the analysis of this public use dataset to increase knowledge of adolescent health and development. More information about the ABCD Study may be found on the ABCD Study web page (<a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.abcdstudy.org&d=DwMFAg&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=P1IDwTp7bh2kFrra4asUvI0SgxBtA_0Kp5mBH7U-5Mw&s=bgyVZTCskpiDsqE4vOYyRr3AVzvrzbXw5eQej6Gl8kU&e=">www.abcdstudy.org</a>).<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">Standard dates apply. Expires September 8, 2021.
<span style="color:red">Med-RA deadline to receive draft documents for new June 5 R01 submission: May 22. Med-RA deadline to receive draft documents for new July 16 R21 submission: July 1.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><span style="font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">Methods Development for Cryogenic or Other Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R21 Clinical Trial Not Allowed)<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__grants.nih.gov_grants_guide_pa-2Dfiles_PAR-2D19-2D176.html&d=DwMFAg&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=P1IDwTp7bh2kFrra4asUvI0SgxBtA_0Kp5mBH7U-5Mw&s=q6jeKyx6qmKaXReX26oK9yY5qojBBTk57j0jdzML8cs&e=" target="_blank">R21</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino">This funding opportunity announcement (FOA) supports exploratory research projects aimed at developing cryogenic or other long-term preservation and revival approaches for Drosophila or zebrafish genetic
stocks, which are essential laboratory animal models for biomedical research. The proposed project should address critical knowledge and technology gaps and describe approaches towards the development of reliable, easy-to-use and cost effective cryogenic or
other long-term preservation and revival methods for wild-type and mutant strains of Drosophila or zebrafish.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">Standard dates apply. Expires May 8, 2022.
<span style="color:red">Med-RA deadline to receive draft documents for new July 16 R21 submission: July 1.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><b><span style="font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 / R01 Clinical Trial Not Allowed)<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__grants.nih.gov_grants_guide_pa-2Dfiles_PAR-2D19-2D173.html&d=DwMFAg&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=P1IDwTp7bh2kFrra4asUvI0SgxBtA_0Kp5mBH7U-5Mw&s=aQW7Jx0Oih7UlJL-ksnOPGYEekZG-zMj_2IhlsMzAVw&e=" target="_blank">R21</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__grants.nih.gov_grants_guide_pa-2Dfiles_PAR-2D19-2D172.html&d=DwMFAg&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=P1IDwTp7bh2kFrra4asUvI0SgxBtA_0Kp5mBH7U-5Mw&s=ONGyxmVHNOrx_9i4eXBi0Z8_g-7Vc7pu9rK_SxHNosY&e=" target="_blank">R01</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino">These funding opportunity announcements (FOAs) encourage state-of-the-art, systematic research approaches to elucidate the role of immune system plasticity in health and in the pathogenesis of dental,
oral, and craniofacial (DOC) diseases. These FOAs encourage applications that will seek to determine mechanisms underlying the ability or inability of the immune system to dynamically maintain its functional role against internal and external perturbations.
The expectation is that new knowledge derived from this research will facilitate development of novel, personalized immunomodulatory-based therapies that shift the balance between degenerative and regenerative processes toward regeneration disease management
in a patient-specific manner across the lifespan.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">Standard dates apply. Expires May 8, 2022.
<span style="color:red">Med-RA deadline to receive draft documents for new June 5 R01 submission: May 22. Med-RA deadline to receive draft documents for new July 16 R21 submission: July 1.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><span style="font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino">To search for additional funding opportunities, please visit <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV6980C-DCl-AxzFLHMVYQ&e=">CoM’s
unofficial funding opportunities blog</a>.<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>